Cardiac Resynchronization Therapy, Remodeling, and Outcome in Patients With Amyloid Transthyretin Cardiomyopathy
Journal of the American Heart Association · 18.11.2025 · 14 (22)
DOI: 10.1161/jaha.125.043049 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 18.11.2025. Verfasst von Alberto Aimo und 36 weiteren Autor:innen. Beteiligte Einrichtung: Scuola Superiore Sant'Anna Pisa Italy. Hauptthemen laut MEDLINE: Cardiac Resynchronization Therapy, Amyloid Neuropathies, Familial, Ventricular Remodeling, Cardiomyopathies. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Transthyretin amyloid cardiomyopathy (ATTR‐CM) has a specific pathophysiology, with myocardial stiffening and systolic dysfunction only in advanced stages. We aimed to investigate the response to cardiac resynchronization therapy (CRT) in ATTR‐CM compared with heart failure.
Methods
In this multicenter, observational study, patients with ATTR‐CM receiving CRT (n=101) were matched to patients without amyloid cardiomyopathy by sex, age, and implantation type (CRT with versus without defibrillator versus conduction system pacing, upgrade versus first implant). We evaluated changes in QRS duration and echocardiographic parameters following CRT implantation and at the most recent available assessments. The study end points were all‐cause death alone or combined with heart failure hospitalization.
Results
Patients with ATTR‐CM (median age, 76 [interquartile range, 72–83] years, 98% men, left ventricular (LV) ejection fraction 30% [26–33]) showed greater QRS shortening after CRT implantation ( P =0.012), but not after a median of around 1 year ( P =0.152). There were no significant differences in the absolute LV ejection fraction changes immediately after implantation (+7 [+2/+10] versus +3 [0/+9] units; P =0.124), or to the last echo ( P =0.796), which was performed after 1.3 years in patients with ATTR‐CM and 2.9 years in patients without amyloid cardiomyopathy. Patients with ATTR‐CM had a shorter survival than controls ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Scuola Superiore Sant'Anna Pisa Italy.
- Fondazione Toscana Gabriele Monasterio Pisa Italy.
- Mayo Clinic Rochester MN USA.
- Columbia University New York City NY USA.
- ASST Spedali Civili di Brescia and University of Brescia Italy.
- University Hospital of Bari Italy.
ORCID-Profile: Alberto Aimo, Martina Nesti, Giuseppe Vergaro, Ammar M Killu, Daniela Tomasoni, Cinzia Forleo, Francesco Musca, Julie Rosenthal, Sergio L Teruya, Nader J Al-Shakarchi, Vincenzo Castiglione, Aldostefano Porcari, Vera Fico, Andrea I Guaricci, Giacomo Tini, Alberto Cipriani, Simone Longhi, Cristina Chimenti, Marco Metra, Martha Grogan, Federico Perfetto, Francesco Cappelli, Marco Merlo, Gianfranco Sinagra, Mathew S Maurer, Ahmad Masri, Michele Emdin
Zitieren
APA
Aimo, A., Nesti, M., Vergaro, G., Killu, A. M., Bampatsias, D., Tomasoni, D., Forleo, C., Musca, F., Serenelli, M., Rosenthal, J., Teruya, S. L., Al-Shakarchi, N. J., Tameze, M. S., Castiglione, V., Nicolai, A., Panichella, G., Saro, R., Porcari, A., Sinigiani, G., …, & Emdin, M. (2025). Cardiac Resynchronization Therapy, Remodeling, and Outcome in Patients With Amyloid Transthyretin Cardiomyopathy. Journal of the American Heart Association, 14(22). https://doi.org/10.1161/jaha.125.043049
Vancouver
Aimo A, Nesti M, Vergaro G, Killu AM, Bampatsias D, Tomasoni D, et al. Cardiac Resynchronization Therapy, Remodeling, and Outcome in Patients With Amyloid Transthyretin Cardiomyopathy. Journal of the American Heart Association. 2025;14(22). doi:10.1161/jaha.125.043049
BibTeX
@article{Aimo2025,
author = {Aimo, Alberto and Nesti, Martina and Vergaro, Giuseppe and Killu, Ammar M and Bampatsias, Dimitrios and Tomasoni, Daniela and Forleo, Cinzia and Musca, Francesco and Serenelli, Matteo and Rosenthal, Julie and Teruya, Sergio L and Al-Shakarchi, Nader J and Tameze, Mariel S and Castiglione, Vincenzo and Nicolai, Alessio and Panichella, Giorgia and Saro, Riccardo and Porcari, Aldostefano and Sinigiani, Giulio and Fico, Vera and Frau, Elisa and Matar, Reem and Guaricci, Andrea I and Tini, Giacomo and Cipriani, Alberto and Musumeci, Maria B and Longhi, Simone and Chimenti, Cristina and Metra, Marco and Grogan, Martha and Perfetto, Federico and Cappelli, Francesco and Merlo, Marco and Sinagra, Gianfranco and Maurer, Mathew S and Masri, Ahmad and Emdin, Michele},
title = {Cardiac Resynchronization Therapy, Remodeling, and Outcome in Patients With Amyloid Transthyretin Cardiomyopathy},
journal = {Journal of the American Heart Association},
year = {2025},
volume = {14},
number = {22},
doi = {10.1161/jaha.125.043049}
}
EUVIMED